In conclusion, the findings from this large cohort study demonstrate that high SATB2 expression is an independent factor of good prognosis in colon cancer and imply a putative role for SATB2 in mediating increased sensitivity to chemotherapy and radiation therapy in CRC. Here, SATB2 is linked to malignant colon neoplasm.